This early TNFα effect mediated by the tumor microenvironment has also been shown for STING agonists in the absence of radiation treatment (Francica et al., 2018), indicating the importance of understanding how STING agonists affect normal tissue in order to optimize clinical implementation. This evidence concerns the gene STING1 and neoplasm.